- Clinical Essentials from HIV Med
- 1 comment
Data from a Dutch nationwide prospective study.
Rituximab had the greatest impact in decreasing fatigue at 1 mo.
CPR international consensus recommendations | A call for newborn CHD screening | ACC decision pathway for bleeding management with anticoagulants.
WSG-ADAPT-TN randomized trial reveals higher pCR rate and fewer adverse events.
Evidence for 5-year effectiveness and safety.
One exception is urgent surgery.
There may be increased susceptibility at later age.
Hemophilia-related mortality less likely related to cardiac complications and cancer.
Adding pazopanib to paclitaxel boosts toxicity, but not survival.
Drug showed significant improvement in time to normalization of platelet count.
It’s as effective as face-to-face training, and both are better than usual care.
Carboplatin is the preferred treatment, but thromboembolism risk was understudied.
Data from over 141K individuals in 2 prospective cohorts shows no association.
Studies show mixed results in these patients.
An observational cohort study of a care model used in the Netherlands.